Novalgen licenses mAbsolve’s technology to improve the safety of therapeutic antibodies
A new generation of antibody variant developed by mAbsolve has been licensed to Novalgen for evaluation in their ...
Read More ONA Therapeutics sign licence to STR technology
The STR antibody technology developed by mAbsolve for truly silenced antibodies has been licensed to ONA Therapeutics for ...
Read More mAbsolve launches STR, a novel Fc silencing technology available to licence
After a period of research and development mAbsolve today announces the formal launch of its Fc silencing technology ...
Read More mAbsolve files patent on novel Fc silencing technology
mAbsolve has today filed a patent on its novel Fc silencing technology, GB2007613.9.
Read More mAbsolve spins-out of Absolute Antibody with novel Fc silencing technology
A novel Fc silencing technology developed at Absolute Antibody has been formally spun-out into a new business entity ...
Read More - « Previous
- 1
- 2
- 3
- 4